Working with Industry
Introduction:
The Experimental Cancer Medicine Centres Network acts as a single point of entry to a UK wide network of scientific and clinical experts to help deliver early-phase innovative trials, driving the development of cancer treatments of tomorrow. We have access to a pan-age patient population through our integration with the NHS.
By 2022, Cancer Research UK, the National Institute of Health Research in England and the Health Departments for Scotland, Wales and Northern Ireland will have invested over £100m in the ECMC network's research infrastructure to support the delivery of trials.
What can the ECMC Network offer Industry?
- An opportunity to work with globally recognised key opinion leaders across oncology
- Scientific and operational expertise which includes First in Human, immunotherapy, liquid biopsy, precision medicine and innovative combination therapy models
- Protocol development, feasibility and site placement offering through our streamlined process, including patient referral capabilities
- A broad pan-age patient population
- Visibility of your sponsored trial information across the ECMC clinical network on EC Trial Finder leading to increased opportunity for patient referrals
- Access to study delivery support through the National Institute for Health Research (NIHR)
If your organisation is interested in working with the ECMC Network, please complete the Company Engagement Form or contact us on ecmcadmin@cancer.org.uk for further information.
For more information on our Network and how we can support industry, please see our introductory slide set and trifold.
Supporting your path from lab to clinic
The Programme Office can offer:
- A single point of entry for early feasibility, ECMC site engagement and placement
- A streamlined expression of interest process utilising network-wide standard templates
- A network wide confidentiality agreement - one signature to access 17 adult & 12 paediatric centres
Our Research Capabilities
For more information on our centre capabilities, please visit the Adult Network and Paediatric Network pages.
Our Impact:
